Price Targets on (HLS) (HS) (INFN) (MMI) (MSFT) Updated

Price targets on HealthSouth (NYSE: HLS), HealthSpring, Inc (NYSE: HS), Infinera Corp. (NASDAQ: INFN), Motorola Mobility (NYSE: MMI) and Microsoft Corp (NASDAQ: MSFT) get updated.

Morgan Keegan raised their price target on HealthSouth (HLS) from $29.25 to $32.00.

Jefferies (NYSE:JEF) raised their price target on HealthSpring, Inc (HS) from $46.00 to $48.00. They have a “buy” rating on the company.

Citigroup (NYSE:C) cut their price target on Infinera Corp. (INFN) from $9.50 to $9.00.

JPMorgan Chase & Co. (NYSE:JPM) raised their price target on Motorola Mobility (MMI) from $20.00 to $21.00. They have an “underweight” rating on the company.

UBS AG (NYSE:UBS) cut their price target on Microsoft Corp (MSFT) from $35.00 to $32.00. They have a “buy” rating on the company.

Price Targets on (HLS) (HS) (INFN) (IP) (NYSE: JNJ) Updated

Price targets on HealthSouth (NYSE: HLS), HealthSpring, Inc (NYSE: HS), Infinera Corp. (NASDAQ: INFN), International Paper Company (NYSE: IP) and Johnson & Johnson (NYSE: JNJ) get updated.

Morgan Keegan raised their price target on HealthSouth (HLS) from $29.25 to $32.00.

Jefferies (NYSE:JEF) raised their price target on HealthSpring, Inc (HS) from $46.00 to $48.00. They have a “buy” rating on the company.

Citigroup (NYSE:C) cut their price target on Infinera Corp. (INFN) from $9.50 to $9.00.

Deutsche Bank (NYSE:DB) raised their price target on International Paper Company (IP) from $35.00 to $39.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on Johnson & Johnson (JNJ) from $67.00 to $72.00. They have a “buy” rating on the company.

Price Targets on (HLS) (HS) (INFN) (IP) (JNJ) Updated

Price targets on HealthSouth (NYSE: HLS), HealthSpring, Inc (NYSE: HS), Infinera Corp. (NASDAQ: INFN), International Paper Company (NYSE: IP) and Johnson & Johnson (NYSE: JNJ) were updated today.

Morgan Keegan raised their price target on shares of HealthSouth (HLS) from $29.25 to $32.00.

Jefferies (NYSE:JEF) raised their price target on HealthSpring, Inc (HS) from $46.00 to $48.00. They have a “buy” rating on the company.

Citigroup (NYSE:C) cut their price target on Infinera Corp. (INFN) from $9.50 to $9.00.

Deutsche Bank (NYSE:DB) raised their price target on International Paper Company (IP) from $35.00 to $39.00. They have a “buy” rating on the company.

UBS AG (NYSE:UBS) raised their price target on Johnson & Johnson (JNJ) from $67.00 to $72.00. They have a “buy” rating on the company.

Ratings on (CVH) (EK) (INFN) (GDOT) (HLIT) Reiterated

Analysts reiterate ratings on Coventry Health Care, Inc. (NYSE: CVH), Eastman Kodak Compan (NYSE: EK), Infinera Corp. (NASDAQ: INFN), Green Dot Co. (NASDAQ: GDOT) and Harmonic (NASDAQ: HLIT).

JPMorgan Chase & Co. (NYSE:JPM) reiterated a “neutral” rating on Coventry Health Care, Inc. (CVH). They have a price target of $32.00 on the company.

BMC Equities Research reiterated a “hold” rating on Eastman Kodak Company (EK).

Jefferies (NYSE:JEF) reiterated a “hold” rating on Infinera Corp. (INFN).

JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Green Dot Co. (GDOT). They have a price target of $60.00 on the company.

Jefferies reiterated a “hold” rating on Harmonic (HLIT). They have a price target of $9.00 on the company.

Ratings of (GPRO) (IM) (MEOH) (IMAX) (INFN) Downgraded

Analysts downgraded ratings of Gen-Probe Incorporated (NASDAQ: GPRO), Ingram Micro Inc. (NYSE: IM), Methanex Corporation (NASDAQ: MEOH), Imax Corporation (NASDAQ: IMAX) and Infinera Corp. (NASDAQ: INFN) today.

William Blair downgraded Gen-Probe Incorporated (GPRO) to a “market perform” rating.

Stifel Nicolaus downgraded Ingram Micro Inc. (IM) from a “buy” rating to a “hold” rating.

UBS AG (NYSE:UBS) downgraded Methanex Corporation (MEOH) from a “buy” rating to a “neutral” rating.

Canaccord Genuity downgraded Imax Corporation (IMAX) from a “buy” rating to a “hold” rating.

JPMorgan Chase & Co. (NYSE:JPM) downgraded Infinera Corp. (INFN) to an “underweight” rating.

Blood in the Streets for (JDSU) (OCLR) (OPLK) (CIEN) (INFN) After Finisar (FNSR) Earnings Warning

Shares of JDS Uniphase Corporation (Nasdaq:JDSU), Oclaro, Inc. (Nasdaq:OCLR), Oplink Communications Inc. (Nasdaq:OPLK), CIENA Corp. (Nasdaq:CIEN) and Infinera Corp. (Nasdaq:INFN) are getting crushed today on the weak earnings guidance of Finisar Corp. (Nasdaq:FNSR).

While the third quarter results of Finisar were in line with expectations, its fourth quarter earnings guidance of $0.31-$0.35 was so far below analyst estimates of $0.48 a share that it spoke of probably sector problems.

Finisar said, "the Company will be impacted by the full three months of the annual price negotiations with telecom customers that typically take effect on January 1, the 10-day long shutdown at certain customers for Chinese New Year in February, the adjustment of inventory levels at some telecom customers, particularly for products which had previously been on allocation and long lead times, including WSS and ROADM line cards, and a slowdown in business in China overall."

JDS Uniphase Corporation was trading at $22.31, falling $3.07, or 12.10 percent, as of 11:48 AM EST. Oclaro was at $13.86, dropping $2.76, or 16.61 percent. Infinera Corp. was at $8.15, down $0.20, or 2.40 percent, recovering some from earlier in the session. CIENA Corp. was trading at $24.75, losing $0.93, or 3.63 percent. Oplink Communications Inc. was down to $21.79, plunging $3.83, or 14.95 percent. Finisar was getting crushed at $25.67, down $14.37, or 35.89 percent.

Infinera (Nasdaq:INFN) Downgraded on Scary Guidance

Guidance from Infinera (Nasdaq:INFN) for the first quarter was anemic after their weak fourth quarter results, causing Miller Tabak to downgrade the company and slash its price target on them.

Miller says, "We grossly over estimated Infinera’s prospects last year after the three exceptionally strong quarters Infinera posted. The 4Q and now 1Q resets have been jarring. We are very disappointed with the Infinera guidance for 1Q. Management drew down the backlog in 4Q and has experienced weak orders so far in 1Q and described visibility as very low. They sharply lowered revenue guidance to $90-$97 million for CY 1Q from $117 million just reported for CY 4Q. They also noted they would experience 2 points of Gross Margin pressure and spend in front of revenues in order to position for the 2H availability of their 40G PIC...Cutting CY 2012 estimate to $0.43 from $1.00...Stock will likely be under considerable pressure for the next 2-3 quarters."

Miller Tabak downgrades Infinera (INFN) from Buy to Hold. Infinera closed Friday at $7.37, plunging $1.61, or 17.93 percent. Miller Tabak slashed their price target on Infinera from $18 to $8.